China Accepts Novo Nordisk’s Oral Wegovy Application

China’s drug regulator has accepted Novo Nordisk’s application to sell an oral version of its Wegovy weight-loss drug, according to a Reuters report published on August 27. The regulatory filing in the world’s second-largest pharmaceutical market marks a step for the Danish drugmaker as it chases rival Eli Lilly in the burgeoning anti-obesity sector. Regulatory … Read more

Unitree’s Post-Listing Slump Sparks China Robot Bubble Fears

Unitree shares slumped 45% from their debut peak in late August, dropping by $30 billion after soaring to an early $66 billion valuation on the Shanghai STAR Market, according to Reuters. The steep post-listing selloff for China’s best-known humanoid robot maker has triggered widespread regulatory and investor anxiety over retail losses, retail trading frenzies, and … Read more